|  | Open for comments - SVD-WG004
             | 
      
    
    
      
        
          | Published: November 10, 2015
 Closes:  January 15,
                  2016
 
 | 
      
    
    
    Proposal
    
    SVD-WG004 (ISCN<>HGVS) suggest to extend the current HGVS
      recommendations for the description of sequence variants with the proposal
      below. Comments can be sent to the HGVS/HVP/HUGO Sequence Variant
      Description Working Group (SVD-WG), addressed to "Varnomen
        @ variome.org", Subject:
        SVD-WG004. Comments need to be sent ultimately
        January 15, 2016. 
    HGVS<>ISCN
    The current HGVS recommendations (see
        Recommendations) do not cover translocations. One small example is
      given (see
        DNA sequence variants) but this is insufficient to properly describe
      the changes detected. The SVD-WG has received the request to extend the
      HGVS recommendations to include the description of translocations.
    Historically the description of translocations is the responsibility of
      the ISCN committee. The ISCN recommendations
      cover the description of chromosome numerical and structural changes
      detected using microscopic / cytogenetic techniques, while the HGVS
      recommendations cover the description of changes at the nucleotide level
      detected using sequencing. Given the increased use of sequencing
      technologies to characterize chromosomal abnormalities the ISCN committee
      and the HGVS/HVP/HUGO Sequence Variant Description Working Group (SVD-WG)
      have thoroughly checked and discussed the recommendations of both
      committees. The committees decided to design one format that, wherever
      possible, leaves existing standards intact but that also draws a clear
      border between ISCN and HGVS. Discussions concentrated around earlier
      proposals for the description of translocations, e.g. as presented at the
      HGVS/ASHG
        meeting in Boston (see presentation),
      and a paper from Ordulu
        et al. (2014) reporting sequencing results of structural chromosome
      rearrangements.
      
      The committees
        propose that as soon as nucleotide positions are used in the description
        of rearrangements, HGVS nomenclature is followed and descriptions are
        split in a ISCN part and a HGVS part.
    
      - the basics
 
        - only aberrant findings are described
- both the ISCN-like description of chromosome aberrations and the
          HGVS-like nucleotide variant descriptions must be included for full
          clarity and information
- the ISCN-like portion of the description appears first and can be
          modeled on the short or long form ISCN description of structural
          rearrangements
- the ISCN-like portion of the description begins with "seq"
          to indicate that the aberration was identified by sequence-based
          technology.  The description must include the genome build in
          square brackets after "seq[..]".
- the combined nomenclature uses the existing HGVS standards (see HGVS
            website) for the HGVS-like portion, along with additional
          recommendations outlined below
- HGVS additions
        - aberrations affecting autosomes are listed first (numbers from low
          to high), followed by those affecting sex chromosomes (X then Y)
- to determine the location of the break point, the general HGVS rule
          of maintaining the longest unchanged sequence applies (the 3' rule).
          Break point location is determined by the first break point
          encountered, i.e. from pter of the chromosome with the lowest number
- multiple breakpoints in one chromosome are listed in order of
          occurrence from pter to qter
- variant descriptions are always in the forward orientation (from
          nucleotide 1 to the end of the chromosome), determined by the
          chromosomal origin of the intact centromere
- inverted sequences are described using "inv"
- the start of the chromosome is described as "pter",
          the end as "qter",
            the centromere as "cen"
 NOTE: since
          the genomic reference sequence contains N's at the start/end
          of the chromosome (telomeres) the use of specific nucleotide positions
          is undesirable
 NOTE: the use of "cen"
          helps to recognize the derivative chromosome
- the presence of an additional sequence (marker/ring chromosome) is
          indicated by "add"
 NOTE: "ext" is not available
          since it is already used to describe protein extension variants
- translocation, transposition, ring chromosome and chromothripsis
          break points (junctions) are designated by a "::"
          (double colon)
- non-template sequences ("inserts") at imperfect breakpoints are
          described using the format "::sequence::"
          (e.g. ::AAGTAC:: )
Examples
    Note the format:
        the variant is first described using ISCN nomenclature, next
        using HGVS.
    
      - Translocations
        - balanced
 
          - between short arms chromosomes 2
              and 11
 seq[GRCh37] t(2;11)(p25.1;p15.2)
 g.[chr2:pter_8247756::chr11:15825273_cen_qter]
 g.[chr11:pter_15825272::chr2:8247757_cen_qter]
 
 
          - between long arms chromosomes 2
              and 11, with 5 bp deletion of chr11 sequence 
 seq[GRCh37] t(2;11)(q31.1;q22.3)
 g.[chr2:pter_cen_174500098::chr11:108111987_qter]
 g.[chr11:pter_cen_108111981::chr2:174500099_qter]
 NOTE:
              coupling chr11:108111981 to 108111987 implies nucleotides
              108111982_108111986 are deleted
 
          - between short
                arm chromosome 3 and long
                arm chromosomes 14, with insertion of non-templated
              sequence at the break point on the derivative 3 chromosome 
 seq[GRCh37]
            t(3;14)(14qter->14q12::3p22.2->3qter;14pter->14q12::3p22.2->3pter)
 g.[chr14:pter_cen_29745313::chr3:pter_36969141inv]
 g.[chr14:29745314_qterinv::CATTTGTTCAAATTTAGTTCAAATGA::chr3:36969142_cen_qter]
 
 
          - between homologous chromosomes
              (based on Ordulu et al. example) 
 seq[GRCh37] t(9;9)(9qter->9q22.33::9p21.2->9qter;9pter->9q22.33::9p21.2->9pter)
 g.[chr9:102425452_qterinv::chr9:26393002_cen_qter]
 g.[chr9:pter_cen_102425451::chr9:26393001pterinv]
 
 
- unbalanced
          - derivative chromosome 2,
              translocation between short arms chromosomes 2 and 11
 seq[GRCh37] der(2)t(2;11)(p25.1;p15.2)
 g.[chr2:pter_8247756delinschr11:pter_15825266]
 
- derivative chromosome 3,
              translocation between long arms chromosomes 3 and 8, with an
              estimated nucleotide range for the break point on chromosome 8
              (based on Uncertain Break point Localization example from Ordulu
              et al.)
 seq[GRCh37]
            der(3)(3pter->3q25.32::8q24.21->8qter)
 g.[chr3:158573187_qterdelinschr8:(128534000_128546000)_qter]
 
- derivative chromosome 5,
              translocation between short arm chromosome 5 and long arm
              chromosome 10 with homology at the break point (chr5 29658440_29658442
              and chr10 67539995_67539997,
              based on Homology examples in Ordulu et al.)
 seq[GRCh37] der(5)t(5;10)(p13.3;q21.3)
 g.[chr5:pter_29658442delinschr10:67539995_qterinv]
 
 
- Inversion, pericentric
 
        - with substitution at break point
 seq[GRCh37]
          inv(6)(pter->p25.3::q16.1->p25.3::q16.1->qter)
 chr6:g.[776788_93191545inv;93191546T>C]
 
- de novo with 275bp deletion and
            1bp insertion at break points
 seq[GRCh37]
          inv(2)(pter->p22.3::q31.1->p22.3::q31.1->qter)dn
 chr2:g.[32310435_32310710del;32310711_171827243inv;insG]
 
- Deletion
 
        - within a chromosome (based on
            Ordulu et al. Fig 1D)
 seq[GRCh37] del(X)(q21.31q22.2)
 chrX:g.89555676_100352080del
 
- ring chromosome derived from
            chromosome 22
 seq[GRCh37] r(22)(p11.2q13.1)
 chr22:g.[pter_10000000del::40000000_qterdel]
 NOTE: 
          "::"  is used to indicate the join instead of ";" to describe two
          not connected deletions
 
- Insertion
        - Duplication 
          (tandem)
 
          - within a chromosome, orientation
              same relative
                to original sequence (based on Ordulu et al. Fig 5)
 seq[GRCh37] dup(8)(q24.21q24.21)
 chr8:g.128746677_128749160dup
 
- within a chromosome, orientation
              reversed relative to original sequence
 seq[GRCh37] dup(8)(q24.21q24.21)
 chr8:g.128746677_128749160dupinv
 
- Insertion
          - inserted sequence reversed in
              orientation relative to chromosome sequence containing centromere
 seq[GRCh37]
            der(4)ins(4;X)(q28.3;q22.2q21.31)
 g.[chr4:134850793_134850794inschrX:89555676_100352080inv]
- Transposition
 
        
          - balanced  (deletion + insertion elsewhere)
 
            - (balanced
                  intrachromosomal) inserted sequence same orientation as
                chromosome sequence containing centromere (based on Ordulu et
                al. Fig.1C)
 seq[GRCh37] ins(4;X)(q28.3;q21.31q22.2)
 g.[chr4:134850793_134850794inschrX:89555676_100352080] 
              chrX:g.89555676_100352080del
 
          
            - (balanced intrachromosomal)
                inserted sequence reversed in orientation relative to chromosome
                sequence containing centromere
 seq[GRCh37] ins(4;X)(q28.3;q22.2q21.31)
 g.[chr4:134850793_134850794inschrX:89555676_100352080inv] 
              chrX:g.89555676_100352080del
 
- Additional chromosome
 
        - supernumerary ring chromosome
            derived from chromosome 22
 seq[GRCh37] +r(22)(p11.2q13.1)
 chr22:g.add[pter_10000000del::40000000_qterdel]
    | Varnomen
          homepage | Comments homepage | Symbols,
          codons, etc. |
      
    
      
        
          | Copyright
                  © HGVS 2010 All Rights ReservedWebsite Created by Rania Horaitis, Nomenclature by J.T. Den
                Dunnen - Disclaimer
 |